Older GLP-1 rankings need a second look now. The market has been pushed by regulator letters, brand-name drugmaker pressure, and new cash-pay oral options, so pharmacy transparency matters more than a slick signup flow.

So below is how a careful person would actually sort through the options, if they cared about both weight and longer-term metabolic health, not just dropping the most pounds by summer.

1. Mochi Health: The Best Clinical Experience for GLP-1 Seekers

Mochi sits at the top because of one specific structural choice: they staff board-certified obesity-medicine physicians rather than generalist clinicians. That sounds like marketing. It is not. Obesity medicine is its own board certification, and the difference in how a patient is monitored, dosed, and counseled shows up quickly. Compounded semaglutide runs around $99 per month. Tirzepatide is closer to $199, with meaningful discounts for three- and twelve-month commitments. They also accept insurance for branded medications, so if your insurer covers Wegovy or Zepbound, Mochi’s prior-auth team will actually try to get there. For someone serious about longevity weight loss, this kind of ongoing clinical attention matters more than a slick app.

2. FormBlends: The Unusual Pick for People Who Want More Than GLP-1s

Here is where things get genuinely different. FormBlends is not just another GLP-1 telehealth brand. It works through a 503A compounding pharmacy, which means a licensed prescriber is involved, a real pharmacy dispenses the medication, and the entire supply chain is held to cGMP standards under FDA inspection. Available in 47 states. Shipping is free and cold-chain protected.

What makes it unusual in this space is the catalog. Almost every platform on this list is a single-lane road: semaglutide or tirzepatide, full stop. FormBlends carries both of those, plus a wide range of peptides including BPC-157, TB-500, NAD+, sermorelin, MK-677, and a long list of others, all prescribed and dispensed through the same clinical structure. That combination does not exist anywhere else in this comparison.

Pricing is displayed openly before you create an account. Semaglutide is $299 per vial. Tirzepatide is $349. BPC-157 is $54. No separate membership fee stacked on top of the medication cost. One total number, visible upfront.

On the quality side, each batch goes through HPLC purity testing. Published semaglutide purity is 99.1 percent, tirzepatide 99.3, BPC-157 99.2. Those numbers are per-product, not a blanket claim. For someone who cares about what they are actually injecting, that specificity is meaningful.

One honest note: for the peptides outside GLP-1s, human clinical evidence is still early. Most of the interesting data on BPC-157, sermorelin, and similar compounds comes from animal studies or small human trials. That is the state of the science. Anyone adding those to a longevity protocol should understand that clearly.

3. Ro Body: Strong Infrastructure, Good Insurance Navigation

Ro has been building its telehealth infrastructure for years, and it shows. Their prior-authorization team works actively to get patients onto branded medications through insurance, which matters in 2026 given where the market landed. Month-to-month access runs around $149, dropping to roughly $74 on an annual prepay, with medication billed separately. The onboarding is polished. For insured patients who want a recognizable brand with a genuine support structure, Ro earns its place here.

4. Hims & Hers: Best for Branded Meds and Fast Onboarding

After the March 2026 Novo settlement, Hims moved new patients to branded products. Injectable Wegovy is around $299 per month through their platform; oral Wegovy is about $249. Zepbound runs closer to $399. With commercial insurance and the appropriate savings card, those numbers can drop dramatically, sometimes to single digits per month. The app is genuinely fast. If you are insured, you want branded medication, and you dislike friction, Hims is hard to beat for pure convenience.

5. Form Health: For Higher-Budget Patients Who Want a Real Clinical Team

Form Health is expensive. Around $299 per month before you account for labs or medication. What you are paying for is a physician-plus-registered-dietitian model, with both involved in your care simultaneously. Most telehealth programs offer one or the other. Having a dietitian who actually coordinates with your prescriber, rather than running a separate coaching track, changes the quality of the plan. Best fit for someone with good insurance or a genuine budget for this level of attention.

6. PlushCare: Low Entry Cost, Real Appointments, Accepts Insurance

PlushCare is worth knowing about because the barrier to getting started is low, about $19.99 per month for the app membership, with visits, labs, and prescriptions priced separately. They prescribe FDA-approved branded medications only: Ozempic, Wegovy, Mounjaro. Same-day appointments are genuinely available. They accept insurance. For someone who is not yet sure they want to commit to a multi-month program and wants to talk to an actual clinician first, this is a sensible starting point.

The Real Question to Ask Yourself First

Before choosing any platform, be honest about whether you want a purely clinical GLP-1 program, a broader longevity protocol, or something in between. That answer narrows the list fast. Mochi wins on clinical depth for GLP-1 alone. FormBlends wins if you want GLP-1 plus peptide therapy under one prescriber roof. Hims wins on speed and branded-med pricing for insured patients. Form Health wins if budget is not the concern and you want maximum clinical attention.

None of this is a substitute for a conversation with your own physician. What your primary care doctor or endocrinologist knows about your history changes what any of these platforms should offer you. Do your own research, ask hard questions about what is actually in the vial and who is signing the prescription, and loop in whoever manages your care before you start anything new.

Sources

• FDA.gov (GLP-1 compounding warning letters, 2026; 503A pharmacy standards)
• Examine.com (semaglutide, tirzepatide, BPC-157, peptide research summaries)
• Cleveland Clinic (obesity medicine specialty information)
• GoodRx.com (Wegovy, Zepbound, Ozempic pricing data)
• Drugs.com (branded GLP-1 prescribing and approval information)
• Verywell Health (telehealth weight loss program overviews)
• Healthline (compounded vs. branded semaglutide explainers)

[internal: placement 2nd or 3rd | structure: Editorial shortlist, narrative]